https://www.selleckchem.com/pr....oducts/pf-06873600.h
PURPOSE Luminal B-like breast cancer is sensitive to both chemotherapy and endocrine therapy. We aimed to assess the safety and efficacy of concomitant chemotherapy and endocrine therapy compared with chemotherapy alone in the preoperative setting in luminal B-like breast cancer. METHODS This two-arm randomized clinical trial enrolled patients with luminal B-like human epithelial growth factor 2-negative breast cancer, who were randomly assigned at a 11 ratio to receive preoperative chemotherapy alone or preoperative endocrine thera
Like
Comment
Share
